Yi-Min Huang

Dr. Yi-Min Huang

Attending Physician, Department of Internal Medicine, Division of Rheumatology, Immunology and Allergy, National Taiwan University Hospital Yunlin Branch
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Yi-Min HuangYi-Min Huang
Yi-Min Huang
CLChiao Lo
Chiao Lo
CCChiao-Feng Cheng
Chiao-Feng Cheng
CLCheng-hsun Lu
Cheng-hsun Lu
SHSong-Chou Hsieh
Song-Chou Hsieh
KLKo-Jen Li
Ko-Jen Li
Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease mimicking breast cancer. Limited research has been conducted on the application of serum biomarkers. This study aims to investigate the association of serum biomarkers with disease severity in patients with IGM. From November 2011 to March 2020, medical records of patients with IGM were reviewed. Serum cytokine levels were measured in patients and healthy controls between July 2018 and March 2020. A total of 41 patients with histologically proven IGM were found. Serum interleukin (IL)-6 level was significantly higher in patients with IGM (n = 11) than healthy controls (n = 7). Serum IL-6 and C-reactive protein (CRP) levels were significantly higher in patients with severe disease than mild and moderate disease. Serum IL-6 (Spearman’s ρ = 0.855; p < 0.001) and CRP (Spearman’s ρ = 0.838; p = 0.001) levels were associated with time to resolution. A higher serum CRP level was associated with a longer time to resolution (B = 0.322; p < 0.001) in multiple linear regression analysis. Serum IL-6 and CRP levels can be used as biomarkers for the evaluation of disease severity in IGM. IL-6 may play a crucial role in the immunopathology of IGM.

30 July 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Yi-Min HuangYi-Min Huang
Yi-Min Huang
CLCheng-Hsun Lu
Cheng-Hsun Lu
CCChiao-Feng Cheng
Chiao-Feng Cheng
CSChieh-Yu Shen
Chieh-Yu Shen
SHSong-Chou Hsieh
Song-Chou Hsieh
PHPo-Ren Hsueh
Po-Ren Hsueh
To investigate the clinical outcomes and risk factors of mortality in patients with rheumatic diseases complicated by Pneumocystis pneumonia (PCP). Between November 2015 and April 2021, patients with rheumatic diseases with PCP in a tertiary referral hospital were retrospectively enrolled. The diagnosis of PCP requires the fulfillment of clinical, radiographic, and microbiological criteria. Factors associated with in-hospital, 30-day, and 90-day mortality were evaluated. A total of 128 patients with rheumatic diseases who had a positive quantitative polymerase chain reaction assay for Pneumocystis jirovecii were screened, and 72 patients were included in the final analysis. The median (interquartile range [IQR]) pneumonia severity index (PSI) was 101.5 (77.0-132.0). The median (IQR) adjunctive corticosteroid dosage was 0.6 (0.4-0.9) mg/kg/day prednisolone equivalent. The receiver operating characteristic curve analysis showed that the optimal cutoff point of median adjunctive corticosteroid dosage was 0.6 mg/kg/day to predict in-hospital, 30-day, and 90-day mortality. In the multivariable logistic regression analysis, median adjunctive corticosteroid dosage ≥0.6 mg/kg/day and PSI >90 were independent factors of in-hospital, 30-day, and 90-day mortality. A median adjunctive corticosteroid dosage of ≥0.6 mg/kg/day might be associated with mortality in patients with rheumatic diseases complicated by PCP.

16 June 2022 in New England Journal of Medicine
Verified
Journal Article
Closed access
Yi-Min HuangYi-Min Huang
Yi-Min Huang
PLPei-Hsuan Lin
Pei-Hsuan Lin
A 67-year-old man presented to the ophthalmology clinic with swollen eyelids and proptosis. Biopsy of the right lacrimal gland showed a lymphoplasmacytic infiltrate with IgG4-positive plasma cells.

23 June 2020 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Open access
CLCheng-hsun Lu
Cheng-hsun Lu
LCLung-Fang Chen
Lung-Fang Chen
Yi-Min HuangYi-Min Huang
Yi-Min Huang
CCChiao-Feng Cheng
Chiao-Feng Cheng
SHSong-Chou Hsieh
Song-Chou Hsieh
KLKo-Jen Li
Ko-Jen Li
Objectives: The aim of this study was to compare ultrasound (US) grading and laboratory measures in patients with rheumatoid arthritis. Methods: Two-hundred four patients with rheumatoid arthritis who received US evaluation for synovitis were included after excluding those using tocilizumab. Ultrasound grading of synovial hypertrophy (SH) and power Doppler (PD) at the most severe site were recorded. An assessment of the correlation of laboratory measures and US grading was conducted by reviewing the electronic medical records. Results: High-titer anti–cyclic citrullinated peptide (anti-CCP) antibodies positivity was associated with SH grade ≥2 (odds ratio [OR], 6.00; 95% confidence interval [CI], 1.78–20.2) and PD grade ≥2 (OR, 5.56; 95% CI, 1.82–16.9). Recent C-reactive protein (CRP) levels ≥0.3 mg/dL were associated with SH grade ≥2 (OR, 3.13; 95% CI, 1.38–7.10) and PD grade ≥2 (OR, 2.38; 95% CI, 1.31–4.31). Anti-CCP antibody levels correlated with US scores better than the levels of CRP with higher Spearman ρ correlation coefficients. Most of the patients with recent CRP levels <0.3 mg/dL had US synovitis. In logistic regression, high levels of anti-CCP antibodies and CRP were both independently associated with SH grade ≥2 and PD grade ≥2. Conclusions: Higher levels of anti-CCP antibodies and CRP may predict synovitis on US, whereas discrepancies existed between inflammatory markers and US grading. These findings suggest that US has a role in the comprehensive assessment of disease activity, especially for patients with high-titer positive anti-CCP antibodies.

28 January 2026 in European Heart Journal
Verified
Journal Article
Closed access
CWChiueng Fang Wu
Chiueng Fang Wu
Yi-Min HuangYi-Min Huang
Yi-Min Huang
WLWen-Jeng Lee
Wen-Jeng Lee